GABA deficit in the visual cortex of patients with neurofibromatosis type 1: Genotype-phenotype correlations and functional impact

Brain

Volumn 136, Issue 3, 2013, Pages 918-925

  Violante, Inês R ^a   Ribeiro, Maria J ^a   Edden, Richard A E ^b,c   Guimarães, Pedro ^a   Bernardino, Inês ^a   Rebola, José ^a   Cunha, Gil ^a   Silva, Eduardo ^d   Castelo Branco, Miguel ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KENNEDY KRIEGER INSTITUTE   (United States)

^d CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

GABA; neurodevelopmental disorders; neurofibromatosis type 1; spectroscopy; visual cortex

Indexed keywords

4 AMINOBUTYRIC ACID; OXYGEN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MALE; NEUROFIBROMATOSIS; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN BLOOD LEVEL; PRIORITY JOURNAL; SCHOOL CHILD; VISUAL CORTEX;

EID: 84874824926     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws368     Document Type: Article

References (53)

1. Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, et al. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 1990; 63: 851-9.
2. Blin O, Mestre D, Paut O, Vercher JL, Audebert C. GABA-ergic control of visual perception in healthy volunteers: effects of midazolam, a benzodiazepine, on spatio-temporal contrast sensitivity. Br J Clin Pharmacol 1993; 36: 117-24.
3. Bogner W, Gruber S, Doelken M, Stadlbauer A, Ganslandt O, Boettcher U, et al. In vivo quantification of intracerebral GABA by single-voxel (1)H-MRS-How reproducible are the results? Eur J Radiol 2010; 73: 526-31.
4. Chen Z, Silva AC, Yang J, Shen J. Elevated endogenous GABA level correlates with decreased fMRI signals in the rat brain during acute inhibition of GABA transaminase. J Neurosci Res 2005; 79: 383-91.
5. Costa RM, Federov NB, Kogan JH, Murphy GG, Stern J, Ohno M, et al. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature 2002; 415: 526-30.
6. Cui Y, Costa RM, Murphy GG, Elgersma Y, Zhu Y, Gutmann DH, et al. Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell 2008; 135: 549-60.
7. Edden RA, Barker PB. Spatial effects in the detection of gamma-aminobutyric acid: improved sensitivity at high fields using inner volume saturation. Magn Reson Med 2007; 58: 1276-82.
8. Edden RA, Muthukumaraswamy SD, Freeman TC, Singh KD. Orientation discrimination performance is predicted by GABA concentration and gamma oscillation frequency in human primary visual cortex. J Neurosci 2009; 29: 15721-6.
9. Fernandez-Medarde A, Santos E. The RasGrf family of mammalian guanine nucleotide exchange factors. Biochim Biophys Acta 2011; 1815: 170-88.
10. Goddard AW, Mason GF, Appel M, Rothman DL, Gueorguieva R, Behar KL, et al. Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder. Am J Psychiatry 2004; 161: 2186-93.
11. Golan H, Talpalar AE, Schleifstein-Attias D, Grossman Y. GABA metabolism controls inhibition efficacy in the mammalian CNS. Neurosci Lett 1996; 217: 25-8.
12. Gomez R, Behar KL, Watzl J, Weinzimer SA, Gulanski B, Sanacora G, et al. Intravenous ethanol infusion decreases human cortical gamma-aminobutyric acid and N-acetylaspartate as measured with proton magnetic resonance spectroscopy at 4 tesla. Biol Psychiatry 2012; 71: 239-46.
13. Griffiths S, Thompson P, Frayling I, Upadhyaya M. Molecular diagnosis of neurofibromatosis type 1: 2 years experience. Fam Cancer 2007; 6: 21-34.
14. Guilding C, McNair K, Stone TW, Morris BJ. Restored plasticity in a mouse model of neurofibromatosis type 1 via inhibition of hyperactive ERK and CREB. Eur J Neurosci 2007; 25: 99-105.
15. Haris JP, Phillipson OT. Effects of lorazepam on human contrast sensitivity. Psychopharmacology (Berl) 1995; 117: 379-84.
16. Hilfiker S, Pieribone VA, Czernik AJ, Kao HT, Augustine GJ, Greengard P. Synapsins as regulators of neurotransmitter release. Philos Trans R Soc Lond B Biol Sci 1999; 354: 269-79.
17. Jensen JE, Frederick Bde B, Renshaw PF. Grey and white matter GABA level differences in the human brain using two-dimensional, J-resolved spectroscopic imaging. NMR Biomed 2005; 18: 570-6.
18. Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet Med 2010; 12: 1-11.
19. Kayl AE, Moore BD III. Behavioral phenotype of neurofibromatosis, type 1. Ment Retard Dev Disabil Res Rev 2000; 6: 117-24.
20. Kegeles L, Mao X, Gonsalez R, Shungu DC. Evaluation of anatomic variation in macromolecule contribution to the GABA signal using metabolite nulling and the J-editing technique at 3T. Proceedings of the 15th Annual Meeting of ISMRM, Berlin, Germany 2007. P. abstract 391.
21. Khajavi M, Inoue K, Lupski Jr. Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet 2006; 14: 1074-81.
22. Kleschevnikov AM, Belichenko PV, Villar AJ, Epstein CJ, Malenka RC, Mobley WC. Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J Neurosci 2004; 24: 8153-60.
23. Li W, Cui Y, Kushner SA, Brown RA, Jentsch JD, Frankland PW, et al. The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol 2005; 15: 1961-7.
24. Licata SC, Lowen SB, Trksak GH, Maclean RR, Lukas SE. Zolpidem reduces the blood oxygen level-dependent signal during visual system stimulation. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 1645-52.
25. Logothetis NK. What we can do and what we cannot do with fMRI. Nature 2008; 453: 869-78.
26. Marenco S, Savostyanova AA, van der Veen JW, Geramita M, Stern A, Barnett AS, et al. Genetic modulation of GABA levels in the anterior cingulate cortex by GAD1 and COMT. Neuropsychopharmacology 2010; 35: 1708-17.
27. Mescher M, Merkle H, Kirsch J, Garwood M, Gruetter R. Simultaneous in vivo spectral editing and water suppression. NMR Biomed 1998; 11: 266-72.
28. Muthukumaraswamy SD, Edden RA, Jones DK, Swettenham JB, Singh KD. Resting GABA concentration predicts peak gamma frequency and fMRI amplitude in response to visual stimulation in humans. Proc Natl Acad Sci USA 2009; 106: 8356-61.
29. Muthukumaraswamy SD, Evans CJ, Edden RA, Wise RG, Singh KD. Individual variability in the shape and amplitude of the BOLD-HRF correlates with endogenous GABAergic inhibition. Hum Brain Mapp 2012; 33: 455-65.
30. National Institutes of Health Consensus Development Conference. Neurofibromatosis. Conference statement. Arch Neurol 1988; 45: 575-8.
31. Northoff G, Walter M, Schulte RF, Beck J, Dydak U, Henning A, et al. GABA concentrations in the human anterior cingulate cortex predict negative BOLD responses in fMRI. Nat Neurosci 2007; 10: 1515-7.
32. O'Gorman RL, Michels L, Edden RA, Murdoch JB, Martin E. In vivo detection of GABA and glutamate with MEGA-PRESS: reproducibility and gender effects. J Magn Reson Imaging 2011; 33: 1262-7.
33. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971; 9: 97-113.
34. Perrais D, Ropert N. Effect of zolpidem on miniature IPSCs and occupancy of postsynaptic GABAA receptors in central synapses. J Neurosci 1999; 19: 578-88.
35. Puts NA, Edden RA. In vivo magnetic resonance spectroscopy of GABA: a methodological review. Prog Nucl Magn Reson Spectrosc 2012; 60: 29-41.
36. Ramamoorthi K, Lin Y. The contribution of GABAergic dysfunction to neurodevelopmental disorders. Trends Mol Med 2011; 17: 452-62.
37. Ribeiro MJ, Violante IR, Bernardino I, Ramos F, Saraiva J, Reviriego P, et al. Abnormal achromatic and chromatic contrast sensitivity in Neurofibromatosis type 1. Invest Ophthalmol Vis Sci 2012; 53: 287-93.
38. Roberto M, Madamba SG, Moore SD, Tallent MK, Siggins GR. Ethanol increases GABAergic transmission at both pre-and postsynaptic sites in rat central amygdala neurons. Proc Natl Acad Sci USA 2003; 100: 2053-8.
39. Rothman DL, Petroff OA, Behar KL, Mattson RH. Localized 1H-NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci USA 1993; 90: 5662-6.
40. Schrimsher GW, Billingsley RL, Slopis JM, Moore BD III. Visual-spatial performance deficits in children with neurofibromatosis type-1. Am J Med Genet A 2003; 120A: 326-30.
41. Sheikh SN, Martin DL. Elevation of brain GABA levels with vigabatrin (gamma-vinylGABA) differentially affects GAD65 and GAD67 expression in various regions of rat brain. J Neurosci Res 1998; 52: 736-41.
42. Shilyansky C, Karlsgodt KH, Cummings DM, Sidiropoulou K, Hardt M, James AS, et al. Neurofibromin regulates corticostriatal inhibitory networks during working memory performance. Proc Natl Acad Sci USA 2010; 107: 13141-6.
43. Smigielska-Kuzia J, Bockowski L, Sobaniec W, Kulak W, Sendrowski K. Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy (1H-MRS) in children with Down syndrome. Pharmacol Rep 2010; 62: 1070-7.
44. Stagg CJ, Bachtiar V, Johansen-Berg H. The role of GABA in human motor learning. Curr Biol 2011; 21: 480-4.
45. Sumner P, Edden RA, Bompas A, Evans CJ, Singh KD. More GABA, less distraction: a neurochemical predictor of motor decision speed. Nat Neurosci 2010; 13: 825-7.
46. Thoma R, Mullins P, Ruhl D, Monnig M, Yeo RA, Caprihan A, et al. Perturbation of the glutamate-glutamine system in alcohol dependence and remission. Neuropsychopharmacology 2011; 36: 1359-65.
47. Thomson SA, Fishbein L, Wallace MR. NF1 mutations and molecular testing. J Child Neurol 2002; 17: 555-61.
48. Upadhyaya M, Spurlock G, Kluwe L, Chuzhanova N, Bennett E, Thomas N, et al. The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas. Neurogenetics 2009; 10: 251-63.
49. Violante IR, Ribeiro MJ, Cunha G, Bernardino I, Duarte JV, Ramos F, et al. Abnormal brain activation in neurofibromatosis type 1: a link between visual processing and the default mode network. PLoS One 2012; 7: e38785.
50. Waagepetersen HS, Sonnewald U, Larsson OM, Schousboe A. Synthesis of vesicular GABA from glutamine involves TCA cycle metabolism in neocortical neurons. J Neurosci Res 1999; 57: 342-9.
51. Whittle N, Sartori SB, Dierssen M, Lubec G, Singewald N. Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development. Pediatrics 2007; 120: e1465-71.
52. Xu GF, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990; 62: 599-608.
53. Yoon JH, Maddock RJ, Rokem A, Silver MA, Minzenberg MJ, Ragland JD, et al. GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression. J Neurosci 2010; 30: 3777-81.